CIRM awards $2.29 million to support stem cell-based therapy for knee osteoarthritis
The California Institute for Regenerative Medicine (CIRM), California’s stem cell agency, has awarded the biopharmaceutical company Cellular Biomedicine Group Inc. (Nasdaq: CBMG) $2.29 million to support pre-clinical studies of AlloJoinTM, human fat-derived …